The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
The mesenchymal stromal cells dilemma—does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M. E., Remberger, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60690-x · Cited by 2,695
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Ren, G., Zhang, L., Zhao, X., Xu, G., Zhang, Y., Roberts, A. I., Zhao, R. C., & Shi, Y. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2007.11.014 · Cited by 2,101
Horwitz, E. M., Le Blanc, K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Deans, R. J., Krause, D. S., & Keating, A. (2005) · Cytotherapy · doi:10.1080/14653240500319234 · Cited by 2,073
Horwitz, E. M., Gordon, P. L., Koo, W. K. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L., & Hofmann, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132252399 · Cited by 1,650
Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease
Ringdén, O., Uzunel, M., Rasmusson, I., Remberger, M., Sundberg, B., Lönnies, H., Marschall, H.-U., Dlugosz, A., Szakos, A., Hassan, Z., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000214462.63943.14 · Cited by 1,142
Multipotent mesenchymal stromal cells and the innate immune system
Le Blanc, K., & Mougiakakos, D. (2012) · Nature Reviews Immunology · doi:10.1038/nri3209 · Cited by 1,018
DiGirolamo, C. M., Stokes, D., Colter, D., Phinney, D. G., Class, R., & Prockop, D. J. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01715.x · Cited by 879
François, M., Romieu-Mourez, R., Li, M., & Galipeau, J. (2012) · Molecular Therapy · doi:10.1038/mt.2011.189 · Cited by 694
Self-citationBernardo, M. E., Zaffaroni, N., Novara, F., Cometa, A. M., Avanzini, M. A., Moretta, A., Montagna, D., Maccario, R., Villa, R., Daidone, M. G., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4690 · Cited by 694
Nauta, A. J., Westerhuis, G., Kruisselbrink, A. B., Lurvink, E. G. A., Willemze, R., & Fibbe, W. E. (2006) · Blood · doi:10.1182/blood-2005-11-011650 · Cited by 694
Species Variation in the Mechanisms of Mesenchymal Stem Cell-Mediated Immunosuppression
Ren, G., Su, J., Zhang, L., Zhao, X., Ling, W., L'huillie, A., Zhang, J., Lu, Y., Roberts, A. I., Ji, W., et al. (2009) · Stem Cells · doi:10.1002/stem.118 · Cited by 597
von Bahr, L., Batsis, I., Moll, G., Hägg, M., Szakos, A., Sundberg, B., Uzunel, M., Ringden, O., & Le Blanc, K. (2012) · Stem Cells · doi:10.1002/stem.1118 · Cited by 577
Eliopoulos, N., Stagg, J., Lejeune, L., Pommey, S., & Galipeau, J. (2005) · Blood · doi:10.1182/blood-2005-03-1004 · Cited by 558
Self-citationKretlow, J. D., Jin, Y.-Q., Liu, W., Zhang, W. J., Hong, T.-H., Zhou, G., Baggett, L. S., Mikos, A. G., & Cao, Y. (2008) · BMC Cell Biology · doi:10.1186/1471-2121-9-60 · Cited by 466
Russell, K. C., Phinney, D. G., Lacey, M. R., Barrilleaux, B. L., Meyertholen, K. E., & O'Connor, K. C. (2010) · Stem Cells · doi:10.1002/stem.312 · Cited by 438
Kebriaei, P., Isola, L., Bahceci, E., Holland, K., Rowley, S., McGuirk, J., Devetten, M., Jansen, J., Herzig, R., Schuster, M., et al. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2008.03.012 · Cited by 437
Mesenchymal stem cells: a double-edged sword in regulating immune responses
Li, W., Ren, G., Huang, Y., Su, J., Han, Y., Li, J., Chen, X., Cao, K., Chen, Q., Shou, P., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2012.26 · Cited by 435
Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy
Phinney, D. G. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24166 · Cited by 434
DNA methylation pattern changes upon long‐term culture and aging of human mesenchymal stromal cells
Bork, S., Pfister, S., Witt, H., Horn, P., Korn, B., Ho, A. D., & Wagner, W. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2009.00535.x · Cited by 409
François, M., Copland, I. B., Yuan, S., Romieu-Mourez, R., Waller, E. K., & Galipeau, J. (2012) · Cytotherapy · doi:10.3109/14653249.2011.623691 · Cited by 375
Self-citationMesenchymal stromal cell ‘licensing’: a multistep process
Krampera, M. (2011) · Leukemia · doi:10.1038/leu.2011.108 · Cited by 358
Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?
Moll, G., Rasmusson-Duprez, I., von Bahr, L., Connolly-Andersen, A.-M., Elgue, G., Funke, L., Hamad, O. A., Lönnies, H., Magnusson, P. U., Sanchez, J., et al. (2012) · Stem Cells · doi:10.1002/stem.1111 · Cited by 357
Sundin, M., Ringden, O., Sundberg, B., Nava, S., Gotherstrom, C., & Le Blanc, K. (2007) · Haematologica · doi:10.3324/haematol.11446 · Cited by 334
Duijvestein, M., Wildenberg, M. E., Welling, M. M., Hennink, S., Molendijk, I., van Zuylen, V. L., Bosse, T., Vos, A. C. W., de Jonge-Muller, E. S. M., Roelofs, H., et al. (2011) · Stem Cells · doi:10.1002/stem.698 · Cited by 330
Siddappa, R., Licht, R., van Blitterswijk, C., & de Boer, J. (2007) · Journal of Orthopaedic Research · doi:10.1002/jor.20402 · Cited by 320
von Bahr, L., Sundberg, B., Lönnies, L., Sander, B., Karbach, H., Hägglund, H., Ljungman, P., Gustafsson, B., Karlsson, H., Le Blanc, K., et al. (2012) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2011.07.023 · Cited by 318
Interferon-γ-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell
Stagg, J., Pommey, S., Eliopoulos, N., & Galipeau, J. (2006) · Blood · doi:10.1182/blood-2005-07-2793 · Cited by 290
Self-citationFekete, N., Gadelorge, M., Fürst, D., Maurer, C., Dausend, J., Fleury-Cappellesso, S., Mailänder, V., Lotfi, R., Ignatius, A., Sensebé, L., et al. (2012) · Cytotherapy · doi:10.3109/14653249.2012.655420 · Cited by 285
Good Manufacturing Practices Production of Mesenchymal Stem/Stromal Cells
Sensebé, L., Bourin, P., & Tarte, K. (2011) · Human Gene Therapy · doi:10.1089/hum.2010.197 · Cited by 233
Romieu-Mourez, R., François, M., Boivin, M.-N., Stagg, J., & Galipeau, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1549 · Cited by 221
Self-citationBernardo, M. E., Ball, L. M., Cometa, A. M., Roelofs, H., Zecca, M., Avanzini, M. A., Bertaina, A., Vinti, L., Lankester, A., Maccario, R., et al. (2011) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.87 · Cited by 194
Martin, P. J., Uberti, J. P., Soiffer, R. J., Klingemann, H., Waller, E. K., Daly, A. S., Herrmann, R. P., & Kebriaei, P. (2010) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.12.057 · Cited by 176
Mesenchymal stem cells are injured by complement after their contact with serum
Li, Y., & Lin, F. (2012) · Blood · doi:10.1182/blood-2012-03-420612 · Cited by 167
Allogeneic Mesenchymal Stem Cells for Treatment of Experimental Autoimmune Encephalomyelitis
Rafei, M., Birman, E., Forner, K., & Galipeau, J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.157 · Cited by 155
Self-citationFrançois, M., Romieu, R., Stock-Martineau, S., Boivin, M., Bramson, J. L., & Galipeau, J. (2009) · Blood · doi:10.1182/blood-2009-02-207795 · Cited by 146
Self-citationCoutu, D. L., François, M., & Galipeau, J. (2011) · Blood · doi:10.1182/blood-2010-12-321539 · Cited by 140
Self-citationPopulation dynamics of mesenchymal stromal cells during culture expansion
Schellenberg, A., Stiehl, T., Horn, P., Joussen, S., Pallua, N., Ho, A. D., & Wagner, W. (2011) · Cytotherapy · doi:10.3109/14653249.2011.640669 · Cited by 127
Cakouros, D., Isenmann, S., Cooper, L., Zannettino, A. C. W., Anderson, P. J., Glackin, C. A., & Gronthos, S. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06315-11 · Cited by 126
Zhukareva, V. A., Obrocka, M., Houlé, J. D., Fischer, I., & Neuhuber, B. (2010) · Cytokine · doi:10.1016/j.cyto.2010.01.004 · Cited by 125
Surdo, J. L., & Bauer, S. R. (2012) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2011.0736 · Cited by 111
Ex vivo expansion of mesenchymal stromal cells
Bernardo, M. E., Cometa, A. M., Pagliara, D., Vinti, L., Rossi, F., Cristantielli, R., Palumbo, G. A., & Locatelli, F. (2011) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2010.11.002 · Cited by 92
A Mesenchymal Stromal Cell Gene Signature for Donor Age
Alves, H., van Ginkel, J., Gröen, N., Hulsman, M., Mentink, A., Reinders, M. J. T., van Blitterswijk, C., & de Boer, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042908 · Cited by 90
Choumerianou, D. M., Martimianaki, G., Stiakaki, E., Kalmanti, L., Kalmanti, M., & Dimitriou, H. (2010) · Cytotherapy · doi:10.3109/14653249.2010.501790 · Cited by 86
Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells
Samuelsson, H., Ringdén, O. T. H., Lönnies, H., & Blanc, K. L. (2009) · Cytotherapy · doi:10.1080/14653240802684194 · Cited by 84
Forslöw, U., Blennow, O., LeBlanc, K., Ringdén, O. T. H., Gustafsson, B. M., Mattsson, J., & Remberger, M. (2012) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2012.01824.x · Cited by 82
Treatment of graft-versus-host-disease with mesenchymal stromal cells
Kebriaei, P., & Robinson, S. N. (2011) · Cytotherapy · doi:10.3109/14653249.2010.549688 · Cited by 79
Ren, J., Jin, P., Sabatino, M., Balakumaran, A., Feng, J., Kuznetsov, S. A., Klein, H. G., Robey, P. G., & Stroncek, D. F. (2011) · Cytotherapy · doi:10.3109/14653249.2010.548379 · Cited by 77
Liu, K., Yang, Y., & Mansbridge, J. N. (2000) · Tissue Engineering · doi:10.1089/107632700750022189 · Cited by 61
Isakova, I. A., Dufour, J., Lanclos, C., Bruhn, J., & Phinney, D. G. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.06.011 · Cited by 58
Death and inflammation following somatic cell transplantation
Copland, I. B., & Galipeau, J. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0274-8 · Cited by 49
Self-citationCryopreservation and Revival of Human Mesenchymal Stromal Cells
Haack‐Sørensen, M., Ekblond, A., & Kastrup, J. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3584-0_21 · Cited by 39
The immune plasticity of mesenchymal stromal cells from mice and men concordances and discrepancies
Galipeau, J. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e422 · Cited by 36
Self-citationCryopreservation and Revival of Mesenchymal Stromal Cells
Haack‐Sørensen, M., & Kastrup, J. (2011) · Methods in molecular biology · doi:10.1007/978-1-60761-999-4_13 · Cited by 33
Expression of blood group genes by mesenchymal stem cells
Schäfer, R., Schnaidt, M., Klaffschenkel, R. A., Siegel, G., Schüle, M. C., Rädlein, M. A., Hermanutz‐Klein, U., Ayturan, M., Buadze, M., Gassner, C., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08652.x · Cited by 30
The role of nutritional lipids and antioxidants in UV-induced skin cancer
Black, H. S. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/422 · Cited by 30
Variability in chemokine-induced adhesion of human mesenchymal stromal cells
Ciuculescu, F., Giesen, M., Deak, E., Lang, V., Seifried, E., & Henschler, R. (2011) · Cytotherapy · doi:10.3109/14653249.2011.602339 · Cited by 22
Application of Mesenchymal Stromal Cells in Bone Marrow Transplantation for Sensitized Recipients
Xu, L., Fang, J., Hong, D.-L., & Wu, Y. (2011) · Acta Haematologica · doi:10.1159/000333554 · Cited by 3
Cited by
Mesenchymal stem cell perspective: cell biology to clinical progress
Pittenger, M. F., Discher, D. E., Péault, B. M., Phinney, D. G., Hare, J. M., & Caplan, A. I. (2019) · npj Regenerative Medicine · doi:10.1038/s41536-019-0083-6 · Cited by 2,008
“sponsored phase 3 trial of MSC therapy for GVHD following hematopoietic stem cell transplantation did not meet its proposed endpoints across all ages but showed life-saving benefit in the pediatric patients.(127,128) The results did lead to the first approvals for a culture-expanded MSC product for cell therapy agains…”
Extracellular vesicles as a next-generation drug delivery platform
Herrmann, I. K., Wood, M. J. A., & Fuhrmann, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00931-2 · Cited by 1,948
Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
Galipeau, J., & Sensébé, L. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.004 · Cited by 1,819
“Industrialsponsored manufactured allogeneic MSC cells allow for manufacture of up to 1 million doses per donor for mass deployment, whereas a mix of autologous or allogeneic MSCs are used by academic centers, which typically manufacture no more than 10 doses per donor(Galipeau, 2013).”
BackgroundSelf-citationClinical Trials with Mesenchymal Stem Cells: An Update
Squillaro, T., Peluso, G., & Galderisi, U. (2016) · Cell Transplantation · doi:10.3727/096368915x689622 · Cited by 1,395
Mesenchymal stem cells and immunomodulation: current status and future prospects
Gao, F., Chiu, S. M., Motan, D. A. L., Zhang, Z., Chen, L., Ji, H.-L., Tse, H.-F., Fu, Q.-L., & Lian, Q. (2016) · Cell Death & Disease · doi:10.1038/cddis.2015.327 · Cited by 1,121
Metadata
- Authors
- Galipeau, J.
- Venue
- Cytotherapy
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 15
- Issue
- 1
- Pages
- 2-8
- ISSN
- 1465-3249 (ISSN-L)
- OpenAlex
- W2058473775
- Cited by
- 448
- References
- 61
- FWCI
- 32.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.